G Protein-Coupled receptors and heterotrimeric G proteins as cancer drivers
- PMID: 33270228
- PMCID: PMC8849590
- DOI: 10.1002/1873-3468.14017
G Protein-Coupled receptors and heterotrimeric G proteins as cancer drivers
Abstract
G protein-coupled receptors (GPCRs) and heterotrimeric G proteins play central roles in a diverse array of cellular processes. As such, dysregulation of GPCRs and their coupled heterotrimeric G proteins can dramatically alter the signalling landscape and functional state of a cell. Consistent with their fundamental physiological functions, GPCRs and their effector heterotrimeric G proteins are implicated in some of the most prevalent human diseases, including a complex disease such as cancer that causes significant morbidity and mortality worldwide. GPCR/G protein-mediated signalling impacts oncogenesis at multiple levels by regulating tumour angiogenesis, immune evasion, metastasis, and drug resistance. Here, we summarize the growing body of research on GPCRs and their effector heterotrimeric G proteins as drivers of cancer initiation and progression, and as emerging antitumoural therapeutic targets.
Keywords: G protein-coupled receptors; GTPases; angiogenesis; cancer; cancer metabolism; immune therapy; inflammation; metastasis; precision medicine; signal transduction.
© 2020 Federation of European Biochemical Societies.
Figures
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
